在2022年波兰的结核病
Maria Joanna Korzeniewska-Koseła1, Stefan Wesołowski2
1Zakład Epidemiologii i Organizacji Walki z Gruźlicą, Instytut Gruźlicy i Chorób Płuc, Warszawa.
Przeglad epidemiologiczny
|March 18, 2025
概括
波兰的结核病发病率在2022年增加了17.5%,男性和老年人的发病率更高. 波兰比欧盟/欧洲经济区国家显示出更好的细菌学确认和较低的多药耐药结核病率.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战.
- 了解当前的结核病流行病学对于有效的控制策略至关重要.
研究的目的:
- 分析波兰2022年结核病流行病学情况.
- 将波兰的结核病数据与欧盟和欧洲经济区 (EU/EEA) 国家的结核病数据进行比较.
主要方法:
- 对2022年波兰注册结核病例的分析.
- 包括药物敏感性结果和死亡率数据.
- 与欧洲疾病预防和控制中心 (ECDC) 报告进行比较.
主要成果:
- 波兰在2022年登记了4314例结核病例 (每10万人口中有11.4例),比2021年增加了17.5%.
- 细菌学确认率为81.9%,高于欧盟/欧洲经济区平均水平 (70.6%).
- 与欧盟/欧洲经济区 (4.4%) 相比,波兰的多抗药结核病 (MDR-TB) 率较低 (3.1%).
结论:
- 波兰的结核病发病率正在上升,特别是在老年男性中.
- 与欧盟/欧洲经济区相比,波兰在结核病例确认和较低的MDR-TB率方面表现出强势.
- 关于艾滋病毒同时感染和治疗结果的数据缺口需要注意全面的结核病控制.
相关概念视频
Pulmonary Tuberculosis II
202
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
202
Pulmonary Tuberculosis I
214
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
214
Pulmonary Tuberculosis V
159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Pulmonary Tuberculosis IV
127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis III
283
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
283
Other Pulmonary Disorders
789
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
789


